Protagonist Therapeutics, Inc Stock Prediction
AI-powered sentiment analysis and prediction trends for PTGX, updated each market day.
PTGX AI Sentiment
AI predicts Protagonist Therapeutics, Inc stock is likely to increase over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Protagonist Therapeutics, Inc
Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.
Sector
Exchange
Market Cap
$6,641,530,204
Cap Tier
Employees
132
Headquarters
NEWARK, CA
Listed Since
Aug. 11, 2016
Website
PTGX Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
PTGX Volatility
Protagonist Therapeutics, Inc has shown moderate price volatility over the last 5 trading days. Moderate volatility indicates normal market activity with typical price fluctuations.
